1987
DOI: 10.1136/jcp.40.1.19
|View full text |Cite
|
Sign up to set email alerts
|

Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
25
0

Year Published

1989
1989
2010
2010

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 54 publications
(26 citation statements)
references
References 20 publications
1
25
0
Order By: Relevance
“…CEA was often used in immunohistochemical studies to distinguish carcinoma cells from reactive mesothelial or mesothelioma cells (14,28). However, it was never used as a RT-PCR marker in serous effusions.…”
Section: Discussionmentioning
confidence: 99%
“…CEA was often used in immunohistochemical studies to distinguish carcinoma cells from reactive mesothelial or mesothelioma cells (14,28). However, it was never used as a RT-PCR marker in serous effusions.…”
Section: Discussionmentioning
confidence: 99%
“…Cultures in which TC either failed to grow or were initially absent were used as a source of MC. Characterisation involved recognition of the following criteria, some of which have been described in the literature (Mouriquand et al, 1978;Whitehead & Hughes, 1975) (Wilson et al, 1987), although there are varied reports in the literature which describe positive staining of some benign MC in wax-embedded tissue (Ghosh et al, 1987) and negative staining in wet-fixed smears (Epenetos et al, 1982). MC used in this study stained positively for both vimentin and keratin, as has been previously reported (Connell & Rheinwald, 1983) whereas epithelial cells were, until recently, believed to express only keratin.…”
Section: Tumour Cellsmentioning
confidence: 99%
“…Carcinoembryonic antigen has been consistently reported to have high frequency of positivity in lung carcinomas, particularly adenocarcinomas (26,27). Reports of CEA immunoreactivity for epithelial ovarian carcinomas, however, are conflicting, ranging from 0% to as high as 69% in serous carcinoma in different series (28).…”
Section: N R Howell Et Al 138mentioning
confidence: 97%